Toggle Main Menu Toggle Search

Open Access padlockePrints

The impact of ageing on the health and wellbeing of people with thalidomide embryopathy: a comparison of the health impact with the general population

Lookup NU author(s): Dr Andrew OwensORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2024 Thalidomide Trust. Purpose: As people living with thalidomide embryopathy (TE) are now entering their seventh decade, we examine the impact of ageing and the prevalence of comorbid health conditions reported in holistic needs assessments (HNAs) by individuals with TE, compare it with an age-matched sample of the general population, and explore the relationship between comorbidities and TE pattern of impairment. Materials and methods: The HNA categories were mapped and compared to those of the Health Survey for England (HSE) and analysed across four impairment groups (A–D). Results: 94% (392/415) of individuals with TE residing in the UK participated in the HNA and consented to a secondary analysis of the data. Less than 2% (5/392) reported no comorbidities; 94% reported nervous system problems; including pain, pins and needles and numbness. Individuals with TE reported a significantly greater number of health comorbidities, including musculoskeletal problems, than the age-matched HSE population. Conclusions: Individuals with TE report significantly more health and well-being concerns than the general population of a similar age. Long-term monitoring is needed to ensure that support and rehabilitation services can meet their evolving needs.


Publication metadata

Author(s): Sagoe K, Owens WA, Loyd R, Varley R

Publication type: Article

Publication status: Published

Journal: Disability and Rehabilitation

Year: 2024

Pages: Epub ahead of print

Online publication date: 06/02/2024

Acceptance date: 16/12/2023

ISSN (print): 0963-8288

ISSN (electronic): 1464-5165

Publisher: Taylor and Francis Ltd

URL: https://doi.org/10.1080/09638288.2024.2307357

DOI: 10.1080/09638288.2024.2307357


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Thalidomide Trust

Share